Bioaffinity Technologies (BIAF): 10% owner sold ~$88K
HRT FINANCIAL LP, 10% owner at Bioaffinity Technologies, sold ~$88K of Bioaffinity Technologies shares.
- ~$88K
- Approx. value · 11K sh @ $8.11
- 129K
- Holds after · shares reported
- Traded
- Sep 23, 2026
- Filed
- Nov 19, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jul 30, 2026Company filing · Form 8-K · Listing noticeReceived a notice from its stock exchange“On July 30, 2026, bioAffinity Technologies, Inc., a Delaware corporation (the “Company”) received written notice (the “Staff Determination”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Staff has determined that the bid price of the Company’s listed securities has closed at less than $1.00 per share over the previous thirty consecutive business…”
- Aug 7, 2026Company filing · Form 8-K · ResultsReported its results
- Aug 12, 2026Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 1 more item)
- Aug 20, 2026Company filing · Form 8-K · Shareholder rights, Bylaws or charterChanged the rights of its shareholders, and changed its bylaws, charter or fiscal year (and 1 more item)
- Sep 22, 2026Insider · 1 personInsiders: 1 purchase (~$163K), 1 sale (~$61K)
- Sep 23, 2026 · this disclosureInsider10% owner sold ~$88K of BIAF shares in the open market
What came next
- Sep 23, 2026Insider · 1 personInsiders: 2 purchases (~$149K), 2 sales (~$88K)
- Sep 24, 2026Insider · 1 personInsiders: 1 purchase (~$231K), 2 sales (~$211K)
- Sep 25, 2026Insider · 1 personInsiders: 1 purchase (~$57K), 2 sales (~$72K)
- Sep 28, 2026Insider · 1 personInsiders: 2 purchases (~$82K), 2 sales (~$106K)
- Sep 29, 2026Insider · 1 personInsiders: 2 purchases (~$160K), 2 sales (~$143K)
- Sep 30, 2026Insider · 1 personInsiders: 1 purchase (~$82K), 1 sale (~$138K)
- Oct 1, 2026Insider · 1 personInsiders: 1 purchase (~$117K), 1 sale (~$268K)
- Oct 8, 2026Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 1 more item)
- Nov 6, 2026Company filing · Form 8-K · ResultsReported its results
- Nov 19, 20265% stakeHRT FINANCIAL LP reported a passive stake (13G) of 10.9%
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Bioaffinity Technologies
For Bioaffinity Technologies, OQRO holds 25 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BIAF page.
Other recent filings by HRT FINANCIAL LP, 10% owner
- SEC Form 4 at Bioaffinity Technologies (BIAF)Nov 19, 2026
- SEC Form 4 at Bioaffinity Technologies (BIAF)Nov 19, 2026
- SEC Form 4 at Bioaffinity Technologies (BIAF)Nov 19, 2026
- SEC Form 4 at Bioaffinity Technologies (BIAF)Nov 19, 2026
- SEC Form 4 at Bioaffinity Technologies (BIAF)Nov 19, 2026
The full history of HRT FINANCIAL LP, 10% owner is on the profile page.
How this filing works
Explore the data
Common questions
Which Bioaffinity Technologies (BIAF) insider traded, and how much?
HRT FINANCIAL LP, 10% owner at Bioaffinity Technologies, sold ~$88K of Bioaffinity Technologies shares. 11K shares at $8.11.
When did it happen, and when was it made public?
Traded: Sep 23, 2026. Filed: Nov 19, 2026. That is 57 days between the two dates.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Bioaffinity Technologies recently?
For Bioaffinity Technologies, OQRO holds 25 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the BIAF page.
Does this mean BIAF stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Bioaffinity Technologies
- SEC Form 4Nov 19, 2026
- SEC Form 4Nov 19, 2026
- SEC Form 4Nov 19, 2026
- SEC Form 4Nov 19, 2026
- SEC Form 4Nov 19, 2026
- SEC Form 4Nov 19, 2026
Everything OQRO holds on this company is on its BIAF page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
